Health outcomes of pediatric rheumatic diseases

Nadia J C Luca1, Brian M Feldman2

  • 1Section of Rheumatology, Department of Paediatrics, University of Calgary and Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.

Insights

Measuring health outcomes in pediatric rheumatic diseases requires comprehensive tools assessing biological, physical, and psychosocial health. Ongoing research aims to refine these measures, especially patient-reported outcomes, for better clinical practice and research in childhood rheumatic conditions.

Area of Science:

  • Pediatric Rheumatology
  • Health Outcomes Research
  • Clinical Measurement

Background:

  • Assessing health outcomes is crucial for pediatric rheumatic diseases in clinical practice and research.
  • Health outcome measures must encompass biological, physical, and psychosocial dimensions.
  • Systematic development and rigorous evaluation (reliability, validity, responsiveness) are essential for measure implementation.

Purpose of the Study:

  • To review current health outcome measures for pediatric rheumatic diseases.
  • To highlight the importance of composite measures for disease activity.
  • To emphasize the growing need for patient-reported outcomes (PROs) and parent-reported outcomes (PAROs).

Main Methods:

  • Systematic review of existing literature on health outcome measures.
  • Identification of measures for specific conditions like juvenile idiopathic arthritis, juvenile systemic lupus erythematosus, and juvenile dermatomyositis.
  • Analysis of measurement properties and incorporation of patient/parent perspectives.

Main Results:

  • Several validated health outcome measures exist, including composite disease activity indices.
  • Tools for physical functioning and health-related quality of life are available.
  • There is a clear trend towards integrating patient-reported and parent-reported outcomes.

Conclusions:

  • Optimal health outcome measurement in pediatric rheumatology requires a multi-dimensional approach.
  • Further research is needed to establish the best methods for capturing patient perspectives.
  • Refined outcome measures will enhance clinical care and research for children with rheumatic diseases.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
539
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
528
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
401